Cargando…
Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease
BACKGROUND/AIMS: We investigated the effect of metabolic dysfunction-associated fatty liver disease (MAFLD) on future mortality and cardiovascular disease (CVD) using a prospective community-based cohort study. METHODS: Individuals from two community-based cohorts who were 40 to 70 years old were pr...
Autores principales: | Moon, Joon Ho, Kim, Won, Koo, Bo Kyung, Cho, Nam H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099391/ https://www.ncbi.nlm.nih.gov/pubmed/34635626 http://dx.doi.org/10.5009/gnl210167 |
Ejemplares similares
-
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study
por: Moon, Joon Ho, et al.
Publicado: (2023) -
Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
por: Moon, Joon Ho, et al.
Publicado: (2021) -
Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
por: Lee, Jung Il
Publicado: (2022) -
Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
por: Jeong, Seogsong, et al.
Publicado: (2022) -
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Han, Eugene, et al.
Publicado: (2022)